Evaluation of a Quadrivalent Shigella flexneri Serotype 2a, 3a, 6, and Shigella sonnei O-Specific Polysaccharide and IpaB MAPS Vaccine

被引:0
|
作者
Boerth, Emily M. [1 ]
Gong, Joyce [1 ]
Roffler, Becky [1 ]
Hancock, Zoe [1 ]
Berger, Lydia [1 ]
Song, Boni [1 ]
Malley, Sasha F. [1 ]
Maclennan, Calman A. [2 ]
Zhang, Fan [1 ]
Malley, Richard [1 ]
Lu, Ying-Jie [1 ]
机构
[1] Harvard Med Sch, Div Infect Dis, Boston Childrens Hosp, Boston, MA 02115 USA
[2] Global Hlth Bill & Melinda Gates Fdn, Enter & Diarrheal Dis, 500 5th Ave N, Seattle, WA 98109 USA
关键词
<italic>Shigella</italic>; MAPS vaccine; OSP; IpaB; quadrivalent; INVASION PLASMID; HEALTHY-ADULTS; LIPOPOLYSACCHARIDE; ANTIGENS; IMMUNOGENICITY; ACETYLATION; CONJUGATE; RESPONSES; CHILDREN; EFFICACY;
D O I
10.3390/vaccines12101091
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Shigellosis is the leading cause of diarrheal deaths worldwide and is particularly dangerous in children under 5 years of age in low- and middle-income countries. Additionally, the rise in antibiotic resistance has highlighted the need for an effective Shigella vaccine. Previously, we have used the Multiple Antigen-Presenting System (MAPS) technology to generate monovalent and quadrivalent Salmonella MAPS vaccines that induce functional antibodies against Salmonella components. Methods: In this work, we detail the development of several monovalent vaccines using O-specific polysaccharides (OSPs) from four dominant serotypes, S. flexneri 2a, 3a, and 6, and S. sonnei. We tested several rhizavidin (rhavi) fusion proteins and selected a Shigella-specific protein IpaB. Quadrivalent MAPS were made with Rhavi-IpaB protein and tested in rabbits for immunogenicity. Results: Individual MAPS vaccines generated robust, functional antibody responses against both IpaB and the individual OSP component. Antibodies to IpaB were effective across Shigella serotypes. We also demonstrate that the OSP antibodies generated are specific to each homologous Shigella O type by performing ELISA and bactericidal assays. We combined the components of each MAPS vaccine to formulate a quadrivalent MAPS vaccine which elicited similar antibody and bactericidal responses compared to their monovalent counterparts. Finally, we show that the quadrivalent MAPS immune sera are functional against several clinical isolates of the serotypes used in the vaccine. Conclusions: This quadrivalent MAPS Shigella vaccine is immunogenicity and warrants further study.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] SOMATIC ANTIGENS OF SHIGELLA - STRUCTURAL INVESTIGATION ON O-SPECIFIC POLYSACCHARIDE CHAIN OF SHIGELLA-DYSENTERIAE TYPE-2 LIPOPOLYSACCHARIDE
    DMITRIEV, BA
    KNIREL, YA
    KOCHETKOV, NK
    HOFMAN, IL
    CAPEK, K
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1977, 76 (02): : 433 - 440
  • [42] Characterization of functional oligosaccharide mimics of the Shigella flexneri serotype 2a O-antigen:: Implications for the development of a chemically defined glycoconjugate vaccine
    Phalipon, A
    Costachel, C
    Grandjean, C
    Thuizat, A
    Guerreiro, C
    Tanguy, M
    Nato, F
    Vulliez-Le Normand, B
    Bélot, F
    Wright, K
    Marcel-Peyre, V
    Sansonetti, PJ
    Mulard, LA
    JOURNAL OF IMMUNOLOGY, 2006, 176 (03): : 1686 - 1694
  • [44] SYNTHESIS OF OLIGOSACCHARIDE FRAGMENTS OF SHIGELLA-FLEXNERI O-SPECIFIC POLYSACCHARIDES - THE SYNTHESIS OF 2 BRANCHED TRISACCHARIDES
    BACKINOWSKY, LV
    GOMTSYAN, AR
    BYRAMOVA, NE
    KOCHETKOV, NK
    BIOORGANICHESKAYA KHIMIYA, 1984, 10 (01): : 79 - 87
  • [45] SYNTHESIS, CHARACTERIZATION, AND CLINICAL-EVALUATION OF CONJUGATE VACCINES COMPOSED OF THE O-SPECIFIC POLYSACCHARIDES OF SHIGELLA-DYSENTERIAE TYPE-1, SHIGELLA-FLEXNERI TYPE-2A, AND SHIGELLA-SONNEI (PLESIOMONAS-SHIGELLOIDES) BOUND TO BACTERIAL TOXOIDS
    TAYLOR, DN
    TROFA, AC
    SADOFF, J
    CHU, CY
    BRYLA, D
    SHILOACH, J
    COHEN, D
    ASHKENAZI, S
    LERMAN, Y
    EGAN, W
    SCHNEERSON, R
    ROBBINS, JB
    INFECTION AND IMMUNITY, 1993, 61 (09) : 3678 - 3687
  • [46] Development of Shigella conjugate vaccines targeting Shigella flexneri 2a and S. flexneri 3a using a simple platform-approach conjugation by squaric acid chemistry
    Kelly, Meagan
    Mandlik, Anjali
    Charles, Richelle C.
    Verma, Smriti
    Calderwood, Stephen B.
    Leung, Daniel T.
    Biswas, Rajib
    Islam, Kamrul
    Kamruzzaman, Mohammad
    Chowdhury, Fahima
    Khanam, Farhana
    Vann, Willie F.
    Khan, Ashraful Islam
    Bhuiyan, Taufiqur Rahman
    Qadri, Firdausi
    Vortherms, Anthony R.
    Kaminski, Robert
    Kovac, Pavol
    Xu, Peng
    Ryan, Edward T.
    VACCINE, 2023, 41 (34) : 4967 - 4977
  • [47] Detoxified O-Specific Polysaccharide (O-SP)-Protein Conjugates: Emerging Approach in the Shigella Vaccine Development Scene
    Cohen, Dani
    Meron-Sudai, Shiri
    Bialik, Anya
    Asato, Valeria
    Ashkenazi, Shai
    VACCINES, 2022, 10 (05)
  • [48] MOLECULAR-STRUCTURE OF O-SPECIFIC POLYSACCHARIDE OF SHIGELLA-DYSENTERIAE, TYPE-2
    NIKITIN, IV
    GENIN, AL
    VAINSTEIN, EF
    KUSHNEREV, MJ
    KOCHETKOV, NK
    DOKLADY AKADEMII NAUK SSSR, 1984, 278 (05): : 1133 - 1137
  • [49] Structures of synthetic O-antigen fragments from serotype 2a Shigella flexneri in complex with a protective monoclonal antibody
    Vulliez-Le Normand, B.
    Saul, F. A.
    Phalipon, A.
    Belot, F.
    Guerreiro, C.
    Mulard, L. A.
    Bentley, G. A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (29) : 9976 - 9981
  • [50] STRUCTURE OF CHEMICAL REPEATING-UNIT OF O-SPECIFIC POLYSACCHARIDE CHAIN OF SHIGELLA-BOYDII-6- LIPOPOLYSACCHARIDE
    DMITRIEV, BA
    BACKINOWSKY, LV
    LVOV, VL
    KNIREL, YA
    KOCHETKOV, NK
    KHOMENKO, NA
    CARBOHYDRATE RESEARCH, 1975, 41 (MAY) : 329 - 333